233 related articles for article (PubMed ID: 28696314)
1. Loss-of-function mutation in
Diamantopoulou A; Sun Z; Mukai J; Xu B; Fenelon K; Karayiorgou M; Gogos JA
Proc Natl Acad Sci U S A; 2017 Jul; 114(30):E6127-E6136. PubMed ID: 28696314
[TBL] [Abstract][Full Text] [Related]
2. Age-dependent microRNA control of synaptic plasticity in 22q11 deletion syndrome and schizophrenia.
Earls LR; Fricke RG; Yu J; Berry RB; Baldwin LT; Zakharenko SS
J Neurosci; 2012 Oct; 32(41):14132-44. PubMed ID: 23055483
[TBL] [Abstract][Full Text] [Related]
3. Impaired hippocampal-prefrontal synchrony in a genetic mouse model of schizophrenia.
Sigurdsson T; Stark KL; Karayiorgou M; Gogos JA; Gordon JA
Nature; 2010 Apr; 464(7289):763-7. PubMed ID: 20360742
[TBL] [Abstract][Full Text] [Related]
4. Evidence for altered hippocampal function in a mouse model of the human 22q11.2 microdeletion.
Drew LJ; Stark KL; Fénelon K; Karayiorgou M; Macdermott AB; Gogos JA
Mol Cell Neurosci; 2011 Aug; 47(4):293-305. PubMed ID: 21635953
[TBL] [Abstract][Full Text] [Related]
5. Recapitulation and Reversal of Schizophrenia-Related Phenotypes in Setd1a-Deficient Mice.
Mukai J; Cannavò E; Crabtree GW; Sun Z; Diamantopoulou A; Thakur P; Chang CY; Cai Y; Lomvardas S; Takata A; Xu B; Gogos JA
Neuron; 2019 Nov; 104(3):471-487.e12. PubMed ID: 31606247
[TBL] [Abstract][Full Text] [Related]
6. Differential gene expression in the hippocampus of the Df1/+ mice: a model for 22q11.2 deletion syndrome and schizophrenia.
Sivagnanasundaram S; Fletcher D; Hubank M; Illingworth E; Skuse D; Scambler P
Brain Res; 2007 Mar; 1139():48-59. PubMed ID: 17292336
[TBL] [Abstract][Full Text] [Related]
7. Developmental Inhibition of Gsk3 Rescues Behavioral and Neurophysiological Deficits in a Mouse Model of Schizophrenia Predisposition.
Tamura M; Mukai J; Gordon JA; Gogos JA
Neuron; 2016 Mar; 89(5):1100-9. PubMed ID: 26898776
[TBL] [Abstract][Full Text] [Related]
8. An mGlu5-Positive Allosteric Modulator Rescues the Neuroplasticity Deficits in a Genetic Model of NMDA Receptor Hypofunction in Schizophrenia.
Balu DT; Li Y; Takagi S; Presti KT; Ramikie TS; Rook JM; Jones CK; Lindsley CW; Conn PJ; Bolshakov VY; Coyle JT
Neuropsychopharmacology; 2016 Jul; 41(8):2052-61. PubMed ID: 26741285
[TBL] [Abstract][Full Text] [Related]
9. Abnormalities in behaviour, histology and prefrontal cortical gene expression profiles relevant to schizophrenia in embryonic day 17 MAM-Exposed C57BL/6 mice.
Huo C; Liu X; Zhao J; Zhao T; Huang H; Ye H
Neuropharmacology; 2018 Sep; 140():287-301. PubMed ID: 30056124
[TBL] [Abstract][Full Text] [Related]
10. Loss-of-function of neuroplasticity-related genes confers risk for human neurodevelopmental disorders.
Smith MR; Glicksberg BS; Li L; Chen R; Morishita H; Dudley JT
Pac Symp Biocomput; 2018; 23():68-79. PubMed ID: 29218870
[TBL] [Abstract][Full Text] [Related]
11. Ileal Dysbiosis Is Associated with Increased Acoustic Startle in the 22q11.2 Microdeletion Mouse Model of Schizophrenia.
Yang JC; Troutman R; Buri H; Gutta A; Situ J; Aja E; Jacobs JP
Nutrients; 2023 Aug; 15(16):. PubMed ID: 37630824
[TBL] [Abstract][Full Text] [Related]
12. A Synaptic Function Approach to Investigating Complex Psychiatric Diseases.
Earls LR; Zakharenko SS
Neuroscientist; 2014 Jun; 20(3):257-71. PubMed ID: 23907185
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of miR-185 is a common pathogenic event in 22q11.2 deletion syndrome-related and idiopathic schizophrenia.
Sabaie H; Gharesouran J; Asadi MR; Farhang S; Ahangar NK; Brand S; Arsang-Jang S; Dastar S; Taheri M; Rezazadeh M
Metab Brain Dis; 2022 Apr; 37(4):1175-1184. PubMed ID: 35075501
[TBL] [Abstract][Full Text] [Related]
14. Alteration of Neuronal Excitability and Short-Term Synaptic Plasticity in the Prefrontal Cortex of a Mouse Model of Mental Illness.
Crabtree GW; Sun Z; Kvajo M; Broek JA; Fénelon K; McKellar H; Xiao L; Xu B; Bahn S; O'Donnell JM; Gogos JA
J Neurosci; 2017 Apr; 37(15):4158-4180. PubMed ID: 28283561
[TBL] [Abstract][Full Text] [Related]
15. Derepression of a neuronal inhibitor due to miRNA dysregulation in a schizophrenia-related microdeletion.
Xu B; Hsu PK; Stark KL; Karayiorgou M; Gogos JA
Cell; 2013 Jan; 152(1-2):262-75. PubMed ID: 23332760
[TBL] [Abstract][Full Text] [Related]
16. Subthreshold social cognitive deficits may be a key to distinguish 22q11.2DS from schizophrenia.
Peyroux E; Rigard C; Saucourt G; Poisson A; Plasse J; Franck N; Demily C
Early Interv Psychiatry; 2019 Apr; 13(2):304-307. PubMed ID: 29575660
[TBL] [Abstract][Full Text] [Related]
17. De novo mutations disturb early brain development more frequently than common variants in schizophrenia.
Itai T; Jia P; Dai Y; Chen J; Chen X; Zhao Z
Am J Med Genet B Neuropsychiatr Genet; 2023 Apr; 192(3-4):62-70. PubMed ID: 36863698
[TBL] [Abstract][Full Text] [Related]
18. System-based proteomic and metabonomic analysis of the Df(16)A
Wesseling H; Xu B; Want EJ; Holmes E; Guest PC; Karayiorgou M; Gogos JA; Bahn S
Mol Psychiatry; 2017 Mar; 22(3):384-395. PubMed ID: 27001617
[TBL] [Abstract][Full Text] [Related]
19. Dysregulation of presynaptic calcium and synaptic plasticity in a mouse model of 22q11 deletion syndrome.
Earls LR; Bayazitov IT; Fricke RG; Berry RB; Illingworth E; Mittleman G; Zakharenko SS
J Neurosci; 2010 Nov; 30(47):15843-55. PubMed ID: 21106823
[TBL] [Abstract][Full Text] [Related]
20. Assessing the Cognitive Translational Potential of a Mouse Model of the 22q11.2 Microdeletion Syndrome.
Nilsson SR; Fejgin K; Gastambide F; Vogt MA; Kent BA; Nielsen V; Nielsen J; Gass P; Robbins TW; Saksida LM; Stensbøl TB; Tricklebank MD; Didriksen M; Bussey TJ
Cereb Cortex; 2016 Oct; 26(10):3991-4003. PubMed ID: 27507786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
